An Extension To The B1451027 Protocol To Evaluate The Long Term Safety And Tolerability Of Dimebon In Patients With Alzheimer's Disease

Status:
Terminated

Trial end date:
2010-08-01

Target enrollment:

Participant gender:

The purpose of this study is to evaluate the long-term safety and tolerability of Dimebon in patients with Alzheimer's disease.

Phase 3

Pfizer

Medivation, Inc.